skip to main | skip to sidebar

The Health, Drug, Prescription, and GMP Supersite

Thoughts and resources about health, drugs and prescriptions, and how they are affected by GMPs (FDA Good Manufacturing Practices) and other regulations.

Wednesday, December 25, 2013

Merry Christmas!


Return Home: The Health, Drug, Prescription, and GMP Supersite Blog

SkillsPlus Intl Inc. - The best GMP training, best QSR training, best instructors
SkillsPlus Intl Info Blog

The Exemptee Institute
The Designated Representative Institute

The Health, Drug, Prescription, and GMP Supersite Gift Store 

Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest
Posted by Austin Lee at 4:32 AM

No comments:

Post a Comment

Newer Post Older Post Home
Subscribe to: Post Comments (Atom)

From SkillsPlus International Inc.

Loading...
  • Home
  • SkillsPlus Intl Inc - The Leader in QSR & GMP Training
  • Popular FDA, cGMP, QSR, & GMP Training Courses
  • The Best Exemptee & Designated Representative Training Courses - Online Self-Study
  • CA HMDR Exemptee Certification Class
  • California Exemptee Certification - State Approved
  • The Exemptee Institute
  • The Designated Representative Institute
  • SkillsPlus Intl Inc Blog
  • Home Medical Device Retail - California HMDR Exemptee Training Certification Course
  • Designated Representative Online Training Courses

California Designated Representative Training


Designated Representative Wholesaler Training Course

Designated Representative 3PL Training Course

Designated Representative Reverse Distributor Course

SkillsPlus International Inc. is the ONLY training provider approved by the California State Board of Pharmacy to offer California Designated Representative training programs for wholesalers, 3PL, and reverse distributors. Nearly 10,000 students have taken our state license-related training courses! #2025 #2026 #2027

CA Designated Rep 3PL Course

CA Designated Rep 3PL Course
California Designated Representative 3PL Online Training Course. #2025

The Best Exemptee Training



Sign-up for Exemptee training now!


California HMDR Exemptee license online training certification class for home medical device retailers. Earns a course completion certificate accepted by the California Department of Public Health - Food and Drug Branch. We've added something new, closed captioning. Students can read what the course instructor is teaching. Nearly 10,000 students have taken our state license-related training courses! This feature helps ESL (English as a second language) students, and hard of hearing students. #2025 #2026 #2027

CGMP Online Training Courses

CGMP Online Training Courses
Current Good Manufacturing Practice Training: A New Generation Series - CGMP Online Courses

GMP Trainer Courses

GMP Trainer Courses
GMP Trainer Awareness, Certification, and Master Trainer Courses

Root Cause Analysis - cGMP Training

Root Cause Analysis - cGMP Training
cGMP Training - Online Self-Study Course - Root Cause - Investigation Reports

Subscribe To

Posts
Atom
Posts
Comments
Atom
Comments
Subscribe to The Health, Drug, Prescription, and GMP Supersite by Email

Blog List

  • Medscape Today Headlines
    Preterm Babies May Safely Start Full Milk Feeds on Day 1
    57 minutes ago
  • FiercePharma
    Lilly signs on as 2026 Milan Olympics sponsor, re-ups donations for each Team USA win
    59 minutes ago
  • NPR Blogs: Shots - Health News Blog
    With MAHA on the rise, traditional public health regroups
    2 hours ago
  • Government Executive
    At NSA, a leadership vacuum and staff cuts threaten morale and operational strength
    2 hours ago
  • Medtech Insight
    GE HealthCare Slows Flyrcado Rollout, Strengthens US Launch With CDL Partnership
    2 hours ago
  • eLearning Industry
    How Digital Inspections And eLearning Strategies Are Transforming HVAC Field Training
    2 hours ago
  • All Kaiser Health News
    Qué pueden hacer los consumidores frente al caos del Obamacare
    3 hours ago
  • BioPharma Dive - Latest News
    Blackstone pays Merck $700M to buy into ADC drug royalties
    3 hours ago
  • BioPharma Dive
    Blackstone pays Merck $700M to buy into ADC drug royalties
    3 hours ago
  • Marler Blog
    Pasta Listeria Outbreak – “When in Doubt, Throw it Out”
    5 hours ago
  • FierceBiotech: Medtech
    Olympus updates corrective action related to 2023 lung scope recall
    5 hours ago
  • CNBC Health Care
    Metsera says Novo Nordisk’s new up to $10 billion bid for obesity drugmaker is ‘superior’ to revised Pfizer offer
    5 hours ago
  • GEN Biotech News
    The Pursuit of an Optimal Diagnostic Strategy
    5 hours ago
  • Pharmalot – STAT
    STAT+: Pharmalittle: We’re reading about FDA disarray, microdosing GLP-1 weight loss drugs, and more
    6 hours ago
  • Healthcare Packaging
    Intelligent Data Capture: Paving the Path to a Modern Healthcare Supply Chain
    6 hours ago
  • Clarkston Consulting
    Conducting a Manufacturing and Supply Chain Landscape Assessment for Biopharma Innovation
    7 hours ago
  • Pharmaceutical Commerce
    8 hours ago
  • Drug & Device Law
    Vaccine Court Special Master Says No Evidence Means No Fees.
    9 hours ago
  • Wellness Blog - NY Times
    Is Waking Up to Pee Normal?
    10 hours ago
  • FierceBiotech
    Pfizer's parade of pipeline cuts: Seagen, BioNTech and MASH programs among 11 axed
    10 hours ago
  • Food Poison Journal
    More Listeria recalls linked to Peaches
    14 hours ago
  • FDA What's New: Drugs
    Improving Anaphylaxis Outcomes: Approaches for Enhancing Access to Epinephrine - 12/16/2025
    1 day ago
  • 33 Charts
    The AI coding arms race
    1 day ago
  • Ted Eytan, MD
    Virgin Voyages Valiant Lady
    1 day ago
  • JD Supra Law News
    The Pitch - October 2025
    1 day ago
  • World Pharma - Breaking News
    New switch for programmed cell death identified
    1 day ago
  • Science-Based Medicine
    COVID-19 infection during pregnancy is associated with higher rates of autism and neurodevelopmental diagnoses
    1 day ago
  • FDA - Press Releases
    FDA Acts to Protect Children from Unapproved Fluoride Drug Products
    4 days ago
  • Quality Matters
    Tackling Extractable and Leachable Risks Through Forward-Thinking Collaboration
    5 days ago
  • Drug Channels
    As Pharma Faces Financial Pressure, Pharmacy Delivers Measurable Impact
    5 days ago
  • The Incidental Economist
    Trump’s Prescription Drug Policy: Rhetoric vs. True Reform
    6 days ago
  • Clinical Correlations
    The Original Bird Flu: Chlamydia psittaci
    1 week ago
  • Pharmafile
    BioMedX launches R&D accelerator to advance women’s health
    1 week ago
  • Pharmafile - Mfg & Production
    Sharp invests $100m in US and EU manufacturing and packaging facilities
    1 week ago
  • The Compliance and Ethics Blog
    Why Compliance Is the Cornerstone of Ethical Medical Billing
    2 weeks ago
  • Asbestos and Mesothelioma News
    What the Court Documents Show About J&J’s $966M Loss
    3 weeks ago
  • FDA - Health Fraud
    BIG GUYS Male Energy Supplement contains hidden drug ingredient
    3 months ago
  • Mobihealthnews
    Mendaera gets FDA 510(k) clearance for handheld robotic system
    3 months ago
  • SkillsPlus International Info
    FDA Rushed Out AI Tool
    4 months ago
  • The Health, Drug, Prescription, and GMP Supersite
    Designated Representative Training - California | State-Approved
    4 months ago
  • Modern Healthcare News
    Meet the Administration for a Healthy America, HHS' newest agency
    5 months ago
  • Designated Representative and Exemptee
    Designated Representative Training | Board-Approved Courses | Recommended
    7 months ago
  • Pharma IQ Regulatory-Legal
    AI-Driven Productivity Gains: Transforming Pharma Supply Chain Efficiency
    7 months ago
  • FDA – Policy & Medicine
    FDA Releases Draft Guidance on the Accelerated Approval Process
    8 months ago
  • BioPharma-Reporter RSS
    Inhibikase to pause development of Parkinson’s drug
    9 months ago
  • Outsourcing-Pharma
    Ethris reports positive phase 1 results for asthma mRNA therapy
    9 months ago
  • Outsourcing-Pharma
    Ethris reports positive phase 1 results for asthma mRNA therapy
    9 months ago
  • Biotech Blog
    Making Medicines Affordable: The Role of Generics
    10 months ago
  • BioSpace Regulatory News
    FDA Questions Strength of Evidence Backing Zevra’s Rare Disease Therapy Ahead of Adcomm
    1 year ago
  • Healthy Travel Blog
    Hello world!
    1 year ago
  • Quality Digest - FDA Compliance
    Nine Strategies for Effective Internal Audits
    1 year ago
  • Eye on FDA
    FDA Adds New AdComm to Address Genetic Metabolic Diseases
    1 year ago
  • Designated Representative Training Courses
    The Only Board-Approved California Designated Representative Training Programs For ...
    1 year ago
  • HMDR Exemptee Online Training
    California HMDR Exemptee Online Training Certification Course
    1 year ago
  • Medgadget
    Plant-Based Soft Medical Robots
    1 year ago
  • Drug Injury Watch
    Ozempic / Wegovy: Stomach And Intestinal Problems Can Be Irreversible, Life-threatening
    2 years ago
  • Golf Foodie
    More women in the U.S. are drinking themselves to death, research finds
    2 years ago
  • PharmaPhorum News
    Patient adherence – the key to restoring trust in pharma
    2 years ago
  • Pharma Manufacturing
    How pharma can overcome inflation
    3 years ago
  • Pharmaceutical Industry | Processing & Engineering: Knowledge, News and Analysis | Pharmaceutical Manufacturing
    How pharma can overcome inflation
    3 years ago
  • CA Designated Rep Training
    Recommended! California Designated Representative Online Training Courses
    6 years ago
Show 5 Show All

Blog Archive

  • ►  2025 (1)
    • ►  June (1)
  • ►  2024 (5)
    • ►  August (1)
    • ►  July (1)
    • ►  May (1)
    • ►  March (2)
  • ►  2023 (6)
    • ►  December (1)
    • ►  October (2)
    • ►  July (1)
    • ►  May (1)
    • ►  January (1)
  • ►  2022 (26)
    • ►  November (3)
    • ►  October (1)
    • ►  August (2)
    • ►  July (3)
    • ►  June (4)
    • ►  May (3)
    • ►  April (3)
    • ►  March (1)
    • ►  February (3)
    • ►  January (3)
  • ►  2021 (17)
    • ►  December (2)
    • ►  November (2)
    • ►  October (2)
    • ►  September (2)
    • ►  July (1)
    • ►  April (1)
    • ►  March (1)
    • ►  February (2)
    • ►  January (4)
  • ►  2020 (27)
    • ►  December (5)
    • ►  November (2)
    • ►  October (1)
    • ►  September (4)
    • ►  August (2)
    • ►  July (2)
    • ►  June (2)
    • ►  May (1)
    • ►  April (1)
    • ►  March (2)
    • ►  February (5)
  • ►  2019 (28)
    • ►  December (5)
    • ►  November (2)
    • ►  October (1)
    • ►  September (2)
    • ►  August (3)
    • ►  July (6)
    • ►  June (3)
    • ►  May (2)
    • ►  April (1)
    • ►  February (3)
  • ►  2018 (6)
    • ►  October (1)
    • ►  August (1)
    • ►  July (1)
    • ►  June (1)
    • ►  May (1)
    • ►  January (1)
  • ►  2017 (14)
    • ►  November (1)
    • ►  October (2)
    • ►  August (1)
    • ►  July (1)
    • ►  May (2)
    • ►  April (1)
    • ►  March (1)
    • ►  January (5)
  • ►  2016 (32)
    • ►  December (6)
    • ►  November (4)
    • ►  October (2)
    • ►  September (2)
    • ►  August (2)
    • ►  July (3)
    • ►  June (1)
    • ►  May (3)
    • ►  March (4)
    • ►  February (2)
    • ►  January (3)
  • ►  2015 (68)
    • ►  December (2)
    • ►  November (7)
    • ►  October (10)
    • ►  September (5)
    • ►  August (1)
    • ►  July (6)
    • ►  June (7)
    • ►  May (5)
    • ►  April (3)
    • ►  March (3)
    • ►  February (13)
    • ►  January (6)
  • ►  2014 (105)
    • ►  December (10)
    • ►  November (9)
    • ►  October (1)
    • ►  September (9)
    • ►  August (4)
    • ►  July (6)
    • ►  June (11)
    • ►  May (10)
    • ►  April (10)
    • ►  March (11)
    • ►  February (15)
    • ►  January (9)
  • ▼  2013 (127)
    • ▼  December (7)
      • Merry Christmas!
      • Report: Christmas will kill you | National Monitor
      • We Moved Forward on Many Fronts This Year | FDA Voice
      • Expert Panel Want BP Cuffs Loosened - MedPage Today
      • FDA Drug Quality and Security Act Stakeholder Disc...
      • Procedure Writing Course
      • Nanotech Roundup: Latest National Nanotechnology I...
    • ►  November (14)
    • ►  October (7)
    • ►  September (11)
    • ►  August (7)
    • ►  July (9)
    • ►  June (9)
    • ►  May (6)
    • ►  April (8)
    • ►  March (22)
    • ►  February (9)
    • ►  January (18)
  • ►  2012 (172)
    • ►  December (8)
    • ►  November (20)
    • ►  October (10)
    • ►  September (8)
    • ►  August (4)
    • ►  July (22)
    • ►  June (23)
    • ►  May (17)
    • ►  April (17)
    • ►  March (12)
    • ►  February (13)
    • ►  January (18)
  • ►  2011 (116)
    • ►  December (8)
    • ►  November (15)
    • ►  October (4)
    • ►  September (18)
    • ►  August (9)
    • ►  July (6)
    • ►  June (8)
    • ►  May (9)
    • ►  April (5)
    • ►  March (13)
    • ►  February (10)
    • ►  January (11)
  • ►  2010 (106)
    • ►  December (14)
    • ►  November (8)
    • ►  October (5)
    • ►  September (6)
    • ►  August (10)
    • ►  July (5)
    • ►  June (9)
    • ►  May (11)
    • ►  April (5)
    • ►  March (11)
    • ►  February (10)
    • ►  January (12)
  • ►  2009 (192)
    • ►  December (11)
    • ►  November (11)
    • ►  October (15)
    • ►  September (13)
    • ►  August (10)
    • ►  July (19)
    • ►  June (16)
    • ►  May (16)
    • ►  April (17)
    • ►  March (16)
    • ►  February (19)
    • ►  January (29)
  • ►  2008 (245)
    • ►  December (32)
    • ►  November (39)
    • ►  October (39)
    • ►  September (33)
    • ►  August (52)
    • ►  July (50)

Disclaimer & Privacy Policy

All data and information provided on this site is for informational purposes only. Drughealth.blogspot.com makes no representations as to accuracy, completeness, currentness, suitability, or validity of any information on this site and will not be liable for any errors, omissions, or delays in this information or any losses, injuries, or damages arising from its display or use. All information is provided on an as-is basis. We use third-party advertising companies to serve ads when you visit our website. These companies may use information (not including your name, address, email address, or telephone number) about your visits to this and other websites in order to provide advertisements about goods and services of interest to you. If you would like more information about this practice and to know your choices about not having this information used by these companies, click here.

SkillsPlus International Inc.

SkillsPlus International Inc.
SkillsPlus International Inc. Logo